603259 药明康德
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.07116.61518.89020.71814.361
总资产报酬率 ROA (%)4.45512.27413.88714.71210.052
投入资产回报率 ROIC (%)5.27614.38916.07417.20911.686

边际利润分析
销售毛利率 (%)42.26041.47941.17937.29636.285
营业利润率 (%)44.46329.51029.43027.06726.363
息税前利润/营业总收入 (%)45.07227.40228.49226.35126.633
净利润/营业总收入 (%)38.48424.38224.04622.62122.425

收益指标分析
经营活动净收益/利润总额(%)68.751103.11498.31289.97571.944
价值变动净收益/利润总额(%)34.8546.8561.6579.02220.993
营业外收支净额/利润总额(%)-0.300-0.350-0.341-0.318-0.368

偿债能力分析
流动比率 (X)2.2952.3842.0621.6551.693
速动比率 (X)1.9512.0521.7411.2641.238
资产负债率 (%)25.71626.44324.64027.46029.695
带息债务/全部投入资本 (%)10.13910.0899.43711.85911.730
股东权益/带息债务 (%)857.488861.022914.681705.652701.827
股东权益/负债合计 (%)286.806276.046303.673262.277235.136
利息保障倍数 (X)60.768-13.669-33.994-41.82272.544

营运能力分析
应收账款周转天数 (天)71.17172.71861.90648.44765.110
存货周转天数 (天)95.99379.44878.92884.420105.971